It represents a new class of therapies called triple agonists, meaning it simultaneously activates three key hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
When timer sounds, wash hands, prep site, draw medication, inject, log
5 Benefits of Compound Exercises
DOSING USED IN PHASE 3 STUDIES In the most recent studies from the TRIUMPH programme (Phase 3) , retatrutide was administered as follows: Route: Subcutaneous Frequency: Once weekly Study duration: Approximately 68 weeks Recommended Dosage (Clinical Research Escalation Model) Retatrutide is administered once weekly using a gradual dose escalation to improve tolerability
UK availability will depend on MHRA review and approval, and timelines haven't been confirmed
Over time, this changes your usual habits and can support steady weight loss, especially when paired with daily movement